GeneDx Holdings Corp. (WGS)
Last updated: 2026-10-21 18:04:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
GeneDx Holdings Corp. (WGS) operates in the SERVICES-HEALTH SERVICES sector and is listed on NASDAQ. The stock is currently priced at $70.92, with a market capitalization of $1.98B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $32.21 to $170.87. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.98B | |
$69.16 | |
$170.87 | |
$1.16 | |
$68.74 | |
265.92K | |
723.34K | |
-- | |
$170.87 | |
$32.21 | |
-- | |
-- |
GeneDx Holdings Corp. (WGS) Stock Price Today
GeneDx Holdings Corp. (WGS) is currently trading at $70.92 as of 2026-10-21 18:03:00, up 3.17% ($2.18) from the previous close of $68.74
During today's regular trading session, WGS has traded between $1.16 and $170.87, with a trading volume of 265.92K shares. The current price is near the middle of today's range.
GeneDx Holdings Corp. (WGS) 7-Day Stock Price Change
Over the past seven days, GeneDx Holdings Corp. (WGS) moved from $63.82 to $70.92, representing a gain of 11.12% ($7.10).
The stock traded between $62.01 and $72.70 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 663.77 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
WGS 52-Week Price Position
Position in Range: 27.9%
WGS is currently trading at $70.92, placing it 27.9% of the way from its 52-week low of $32.21 to its 52-week high of $170.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is GeneDx Holdings Corp. (WGS)?
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
GeneDx Holdings Corp. Information
| Industry | SERVICES-HEALTH SERVICES |
| Employees | 1300 |
| Exchange | NASDAQ |
| Company Website |
How to Buy GeneDx Holdings Corp. (WGS) Stock on MEXC
Eligible investors can buy real shares of GeneDx Holdings Corp. (WGS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is GeneDx Holdings Corp. (WGS) stock price today?
2.Is WGS stock going up or down today?
3.What is WGS pre-market price?
4.What is WGS after-hours price?
5.Is WGS stock trading now?
6.Where does WGS sit relative to its 52-week high and low?
7.What sector is GeneDx Holdings Corp. in?
8.What is GeneDx Holdings Corp.'s market capitalization and where is it listed?
9.How is WGS valued in terms of P/E ratio and EPS?
10.Does GeneDx Holdings Corp. pay a dividend?
Explore More US Stocks
Search Stocks
WGS Stock Calculator
Estimate the value between WGS shares and USD.
WGS Shares to USD
1.00 WGS shares = 70.918 USD
Calculations are estimates based on the latest available price and are for reference only.


